This compound is a rhodium-based coordination complex used as a catalyst for asymmetric synthesis. It features a chiral ligand derived from tert-leucine and phthalimide, forming a dirhodium tetracarboxylate structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 380375-05-3
Tetrakis((2S)-2-(1,3-dioxobenzo[de]isoquinolin-2-yl)-3,3-dimethylbutanoate);bis(rhodium(2+))
research reagent
5-Bromo-2-(2-methyl-2H-tetrazol-5-yl)pyridine
research compound
4-Aminotetrahydropyran
research compound
1-Methylnaphthalene-D10
research compound
2-Hydroxy-4-methylpridine-3-carboxylic acid
research compound
Tetrakis[N-phthaloyl-(S)-tert-leucinato]dirhodium
research compound
tetrakis((2R)-2-(1,3-dioxoisoindol-2-yl)-3,3-dimethylbutanoate);ethyl acetate;bis(rhodium(2+))
WEPQIXHMGRKMPK-SVWMVHQSSA-J
CCOC(=O)C.CCOC(=O)C.CC(C)(C)[C@H](C(=O)[O-])N1C(=O)C2=CC=CC=C2C1=O.CC(C)(C)[C@H](C(=O)[O-])N1C(=O)C2=CC=CC=C2C1=O.CC(C)(C)[C@H](C(=O)[O-])N1C(=O)C2=CC=CC=C2C1=O.CC(C)(C)[C@H](C(=O)[O-])N1C(=O)C2=CC=CC=C2C1=O.[Rh+2].[Rh+2]
—